Related Experiment Video
Updated: May 13, 2026
12:58
Characterizing Individual Protein Aggregates by Infrared Nanospectroscopy and Atomic Force Microscopy
Published on: September 12, 2019
Protein fibrillation and nanoparticle interactions: opportunities and challenges
Morteza Mahmoudi1, Hamid R Kalhor, Sophie Laurent
1Department of Nanotechnology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran. mahmoudi@biospion.com
Nanoscale
|March 7, 2013
Summary
Nanoparticles (NPs) offer unique properties for treating brain diseases like Alzheimer's. This review explores how NP characteristics influence protein fibrillation, a key process in neurodegeneration.
Area of Science:
- Biophysics
- Nanotechnology
- Neuroscience
Background:
- Protein fibrillation is central to neurodegenerative diseases.
- Nanoparticles (NPs) possess unique properties due to their small size.
- NPs are emerging as potential therapeutic agents for brain diseases.
Purpose of the Study:
- To review the impact of nanoparticles on protein fibrillation.
- To detail the role of NP biophysicochemical properties in modulating fibrillation.
- To present strategies for controlling NP effects on protein conformational changes.
Main Methods:
- Literature review on nanoparticle-protein interactions.
- Analysis of biophysical and chemical properties of NPs.
- Discussion of NP influence on protein fibrillation kinetics and conformational states.
Main Results:
- NPs interact with various protein states (monomers, oligomers, nuclei).
- NP properties dictate their affinity and influence on fibrillation kinetics.
- NPs can alter protein conformational changes relevant to disease.
Conclusions:
- Nanoparticles show significant potential in managing protein fibrillation in neurodegenerative diseases.
- Understanding NP-protein interactions is crucial for developing targeted therapies.
- Future strategies can leverage NP properties for therapeutic interventions.
